Based on these findings, the potential mechanism of FAM110B regulation of TME is expected to be revealed from more perspectives in the future, and it is also conducive to providing a theoretical basis for personalized treatment of cancer immunotherapy. The gene discussed is FAM110B; the disease is cancer.